Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

81.04
Delayed Data
As of Aug 26
 +0.94 / +1.17%
Today’s Change
55.00
Today|||52-Week Range
133.62
-25.27%
Year-to-Date

Today’s Trading

Previous close80.10
Today’s open80.06
Day’s range79.36 - 82.19
Volume891,449
Average volume (3 months)1,138,639
Market cap$15.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+476.82%
Earnings growth (next 5 years)+118.55%
Revenue growth (last year)+47.36%
P/E ratio213.3
Price/Sales26.95
Price/Book88.38

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+1.25+1.32%
MDVNMedivation Inc+0.11+0.14%
PRGOPerrigo Company PLC+0.13+0.15%
VRXValeant Pharmaceutic...-0.26-0.84%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers

Search for Jobs